Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

1.90
-0.0900-4.52%
Post-market: 1.930.0300+1.58%19:51 EDT
Volume:98.58K
Turnover:190.27K
Market Cap:1.27M
PE:-0.04
High:2.05
Open:1.97
Low:1.90
Close:1.99
Loading ...

Biodexa Says eRapa Gets FDA Fast Track Designation in Familial Adenomatous Polyposis; Shares Rise

MT Newswires Live
·
11 Feb

Biodexa Pharmaceuticals ADRs Rise After Cancer Drug Gets FDA Fast-Track Designation

Dow Jones
·
11 Feb

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis

GlobeNewswire
·
10 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
05 Feb

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading

MT Newswires Live
·
29 Jan

European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading

MT Newswires Live
·
28 Jan

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

MT Newswires Live
·
23 Jan

Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

GlobeNewswire
·
22 Jan

Biodexa Pharmaceuticals files to sell 35.875M ADS for holders

TIPRANKS
·
18 Jan

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week

MT Newswires Live
·
04 Jan

Biodexa Pharmaceuticals price target raised to $18 from $8 at Ladenburg

TIPRANKS
·
02 Jan

European Equities Traded in the US as American Depositary Fall in Monday Trading

MT Newswires Live
·
31 Dec 2024

European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week

MT Newswires Live
·
28 Dec 2024

European Equities Traded in the US as American Depositary Receipts Tumble in Friday Trading; Down 4.6% for Week

MT Newswires Live
·
21 Dec 2024

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week

MT Newswires Live
·
14 Dec 2024

Biodexa Pharmaceuticals Adjusts Share Value Amid Drug Development Focus

TIPRANKS
·
05 Dec 2024